Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Yestar Healthcare Holdings Co Ltd ( (HK:2393) ) just unveiled an update.
Yestar Healthcare Holdings Company Limited has expanded its production capabilities for advanced materials through two equipment acquisitions by an indirect wholly owned subsidiary, purchasing production equipment for US$1.85 million in October 2025 and main equipment for US$5.35 million in February 2026. The transactions, funded by the group’s internal resources and agreed on normal commercial terms, together qualify as discloseable transactions under Hong Kong listing rules, signaling a strategic capital investment that is expected to enhance the company’s manufacturing infrastructure and potentially strengthen its competitive positioning in advanced materials-related healthcare applications.
The most recent analyst rating on (HK:2393) stock is a Sell with a HK$0.11 price target. To see the full list of analyst forecasts on Yestar Healthcare Holdings Co Ltd stock, see the HK:2393 Stock Forecast page.
More about Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Company Limited is a Hong Kong-listed company engaged in healthcare-related businesses, with operations conducted through indirect wholly owned subsidiaries. The group invests in specialized equipment and production capabilities to support its portfolio of medical and advanced material products, targeting markets that require technologically sophisticated manufacturing processes.
Average Trading Volume: 675,463
Technical Sentiment Signal: Sell
Current Market Cap: HK$230.6M
For detailed information about 2393 stock, go to TipRanks’ Stock Analysis page.